Back to results
US 12,583,857 B2Granted
Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines
AssigneePheon Therapeutics Ltd
InventorsPaul Joseph Mark Jackson, David Edwin Thurston, Khondaker Mirazur Rahman
Life of this patent
Estimating the term…
Abstract
The invention relates to substituted pyrridinobenzodiazepines (PDDs) of formula (XVI) and pharmaceutically acceptable salts thereof, which are useful as medicaments, in particular as anti-proliferative agents.
Claims18
A compound of formula (XVI):
- or a pharmaceutically acceptable salt thereof,
- wherein:
- (i) R5 is H;
- and
- R6 is OH or OC1-6 alkyl;
- or
- (ii) R5 and R6, taken together with the N atom and C atom to which they are attached, form N═C;
- L is C1-12 alkylene-;
- Y5 is CH or N;
- q is 1;
- Y1 is CH or N;
- Y2 is CH or N;
- R19 is H or (CH2)tNR20R21;
- t is 0, 1, 2, 3, 4, 5, or 6;
- R20 is H or C1-6 alkyl;
- R21 is H or C1-6 alkyl;
- p is 1;
- Z1 is —NH—, —N(CH3)—, —O—, or —S—;
- Z2 is CH or N;
- R22 is (CH2)jC(O)OH, (CH2)jC(O)OC1-6 alkyl, (CH2)jNR11R12, or C(O)NHR24;
- R24 is phenyl, wherein the phenyl is substituted with one (CH2)jR18 substituent;
- j is 0, 1, 2, 3, 4, 5, or 6;
- R18 is H, C(O)OR11, or NR11R12;
- R11 is H or C1-6 alkyl;
- and
- R12 is H or C1-6 alkyl;
- with the proviso that at least one of Y1 and Y2 is CH.
24 more elements
A compound of the following formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.